UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Accelerated approval of multiple myeloma therapies

Cancer, 2024-08, Vol.130 (16), p.2732-2732

Nierengarten, Mary Beth

2024

Link zum Volltext

Verfügbarkeit prüfen

The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis

Scientific reports, 2024-07, Vol.14 (1), p.16832-10, Article 16832

2024

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions

Pharmaceuticals (Basel, Switzerland), 2024-07, Vol.17 (7), p.901

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.122-9, Article 122

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma

Cancer medicine (Malden, MA), 2024-07, Vol.13 (14), p.e7435-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.117-12, Article 117

2024

Link zum Volltext

Verfügbarkeit prüfen

Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma

NPJ digital medicine, 2024-07, Vol.7 (1), p.200, Article 200

2024

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma

Bioorganic & medicinal chemistry, 2024-09, Vol.111, p.117843, Article 117843

2024

Link zum Volltext

Verfügbarkeit prüfen

Pomalidomide use and kidney outcomes in patients with relapsed/refractory multiple myeloma and chronic kidney disease: A real-world, population-based cohort study

Clinical lymphoma, myeloma and leukemia, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study

Journal of the Formosan Medical Association, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

IgG replacement in multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.124-9, Article 124

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.111-9, Article 111

2024

Link zum Volltext

Verfügbarkeit prüfen

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

Oncology (Williston Park, N.Y.), 2024-06, Vol.38 (6), p.244

2024

Link zum Volltext

Verfügbarkeit prüfen

First person profile: Heather A. Wakelee, MD: For more than 20 years, she has served in multiple functions, including developing research programs in lung cancer and thymoma that include clinical trials and population science approaches

Cancer, 2024-08, Vol.130 (16), p.2730-2730

Nierengarten, Mary Beth

2024

Link zum Volltext

Verfügbarkeit prüfen

Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment

Frontiers in oncology, 2024-07, Vol.14

2024

Link zum Volltext

Verfügbarkeit prüfen

Association between Immunoparesis and treatment outcomes of patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-analysis

Clinical lymphoma, myeloma and leukemia, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic biomarkers of multiple myeloma: A systematic review

Biochimica et biophysica acta. Reviews on cancer, 2024-09, Vol.1879 (5), p.189151, Article 189151

2024

Link zum Volltext

Verfügbarkeit prüfen

Class Ⅱ ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Blood advances, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2380301

2024

Link zum Volltext

Verfügbarkeit prüfen

Unveiling the Correlation Between the Membrane Assembly of P‑gp and Drug Resistance in Multiple Myeloma Using Super-Resolution Fluorescence Imaging

Analytical chemistry (Washington), 2024-07, Vol.96 (29), p.11673-11681

2024

Link zum Volltext

Verfügbarkeit prüfen

Fast and Furious: changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma

Seminars in hematology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Continued Success of Venetoclax in t

Oncology (Williston Park, N.Y.), 2024-06, Vol.38 (6), p.239

2024

Link zum Volltext

Verfügbarkeit prüfen

MULTIDISCIPLINARY CARE

Oncology (Williston Park, N.Y.), 2024-06, Vol.38 (6), p.241

2024

Link zum Volltext

Verfügbarkeit prüfen

Osteolytic mystery: A rare case of pathologic fracture from a phosphaturic mesenchymal tumor in hip and femur

Radiology case reports, 2024-10, Vol.19 (10), p.4413-4416

2024

Link zum Volltext

Verfügbarkeit prüfen

Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7795

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Neu hinzugefügt... seit 30 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(111)
Portugiesisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Reactions Weekly
(14)
Blood Cancer Journal
(5)
Cancer Medicine
(4)
International Journal Of Molecular Sciences
(3)
Oncology
(3)
Pr Newswire
(3)
Blood Advances
(2)
Cancer
(2)
Cancers
(2)
Clinical Lymphoma, Myeloma And Leukemia
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

Accelerated approval of multiple myeloma therapies

The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma

Pomalidomide use and kidney outcomes in patients with relapsed/refractory multiple myeloma and chronic kidney disease: A real-world, population-based cohort study

Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study

IgG replacement in multiple myeloma

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

First person profile: Heather A. Wakelee, MD: For more than 20 years, she has served in multiple functions, including developing research programs in lung cancer and thymoma that include clinical trials and population science approaches

Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment

Association between Immunoparesis and treatment outcomes of patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-analysis

Metabolomic biomarkers of multiple myeloma: A systematic review

Class Ⅱ ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review

Unveiling the Correlation Between the Membrane Assembly of P‑gp and Drug Resistance in Multiple Myeloma Using Super-Resolution Fluorescence Imaging

Fast and Furious: changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma

Continued Success of Venetoclax in t

MULTIDISCIPLINARY CARE

Osteolytic mystery: A rare case of pathologic fracture from a phosphaturic mesenchymal tumor in hip and femur

Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma

Aktive Filter

Suchergebnisse filtern